Particularly, it was reported that melanoma non-responders harbor specific c-KIT mutations known to confer imatinib resistance in GIST, such as D820Y, N822K, and A829P, while responders show mutation on exon 11 or exon 13 [31,32]. Here, KIT is linked to gastrointestinal stromal tumor.